We provide you with 20 years of free, institutional-grade data for NUVA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of NUVA. Explore the full financial landscape of NUVA stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Farrington Michael | Sale | -776 | $42.67 | $33,112 | 2023-03-03 |
| Farrington Michael | Derivatives Exercise | 1,905 | 2023-03-03 | ||
| Barry James Christopher | Sale | -11,505 | $42.67 | $490,918 | 2023-03-03 |
| Barry James Christopher | Derivatives Exercise | 34,284 | 2023-03-03 | ||
| SISITSKY NATHANIEL | Sale | -1,976 | $42.67 | $84,316 | 2023-03-03 |
| SISITSKY NATHANIEL | Derivatives Exercise | 5,333 | 2023-03-03 | ||
| Harbaugh Matthew K | Sale | -3,526 | $42.67 | $150,454 | 2023-03-03 |
| Harbaugh Matthew K | Derivatives Exercise | 12,190 | 2023-03-03 | ||
| Rosenbaum Marc W. | Sale | -745 | $42.67 | $31,789 | 2023-03-03 |
| Rosenbaum Marc W. | Derivatives Exercise | 1,829 | 2023-03-03 | ||
| Wolf Dale A. | Sale | -1,428 | $42.67 | $60,933 | 2023-03-03 |
| Wolf Dale A. | Derivatives Exercise | 4,572 | 2023-03-03 | ||
| Harbaugh Matthew K | Sale | -440 | $41.24 | $18,146 | 2023-01-03 |
| Harbaugh Matthew K | Derivatives Exercise | 1,286 | 2023-01-03 | ||
| Farrington Michael | Initial | 2022-09-08 | |||
| Kadia Siddhartha | Derivatives Exercise | 3,739 | 2022-06-01 | ||
| Norwalk Leslie V | Derivatives Exercise | 1,547 | 2022-06-01 | ||
| Rosenbaum Marc W. | Initial | 2022-05-19 | |||
| Rosenberg Donald J | Derivatives Exercise | 13,326 | 2022-05-13 | ||
| NUVASIVE INC | Initial | 2022-04-22 | |||
| Barry James Christopher | Sale | -5,000 | $58 | $290,000 | 2022-04-15 |
| Barry James Christopher | Sale | -5,000 | $55 | $275,000 | 2022-03-30 |
| Barry James Christopher | Sale | -20,792 | $54.51 | $1,133,372 | 2022-03-03 |
| Barry James Christopher | Derivatives Exercise | 53,523 | 2022-03-03 | ||
| Wolf Dale A. | Sale | -1,239 | $54.51 | $67,538 | 2022-03-03 |
| Wolf Dale A. | Derivatives Exercise | 4,015 | 2022-03-03 | ||
| SISITSKY NATHANIEL | Sale | -2,868 | $54.51 | $156,335 | 2022-03-03 |
| SISITSKY NATHANIEL | Derivatives Exercise | 8,029 | 2022-03-03 | ||
| Barry James Christopher | Sale | -12,343 | $57.4 | $708,488 | 2021-11-09 |
| Barry James Christopher | Derivatives Exercise | 29,904 | 2021-11-09 | ||
| Calafiore Massimo | Sale | -490 | $62.15 | $30,454 | 2021-09-03 |
| Calafiore Massimo | Derivatives Exercise | 1,419 | 2021-09-03 | ||
| Wolf Dale A. | Sale | -1,233 | $62.15 | $76,631 | 2021-09-03 |
| Wolf Dale A. | Derivatives Exercise | 4,256 | 2021-09-03 | ||
| Barry James Christopher | Sale | -5,000 | $70 | $350,000 | 2021-06-29 |
| Barry James Christopher | Sale | -5,000 | $68 | $340,000 | 2021-06-23 |
| Norwalk Leslie V | Derivatives Exercise | 1,548 | 2021-06-03 | ||
| LUCIER GREGORY T | Sale | -8,405 | $70.34 | $591,208 | 2021-05-20 |
| LUCIER GREGORY T | Derivatives Exercise | 19,125 | 2021-05-20 | ||
| Vitale Lucas | Sale | -2,208 | $68.23 | $150,652 | 2021-05-11 |
| Calafiore Massimo | Sale | -3,399 | $68.23 | $231,914 | 2021-05-11 |
| SISITSKY NATHANIEL | Sale | -861 | $71.45 | $61,518 | 2021-05-04 |
| SISITSKY NATHANIEL | Derivatives Exercise | 2,493 | 2021-05-04 | ||
| Vitale Lucas | Sale | -1,167 | $71.45 | $83,382 | 2021-05-04 |
| Vitale Lucas | Derivatives Exercise | 3,375 | 2021-05-04 | ||
| Calafiore Massimo | Sale | -1,794 | $71.45 | $128,181 | 2021-05-04 |
| Calafiore Massimo | Derivatives Exercise | 5,193 | 2021-05-04 | ||
| LUCIER GREGORY T | Sale | -16,722 | $71.45 | $1,194,787 | 2021-05-04 |
| LUCIER GREGORY T | Derivatives Exercise | 42,573 | 2021-05-04 | ||
| Vitale Lucas | Sale | -4,306 | $68.19 | $293,626 | 2021-04-14 |
| Calafiore Massimo | Sale | -3,498 | $68.19 | $238,529 | 2021-04-14 |
The information provided in this report about NUVA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
NuVasive, Inc(NASDAQ:NUVA) 
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. it provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruptio...
Website: http://www.nuvasive.com
Founded: 1997
Full Time Employees: 2,800
Sector: Healthcare
Industry: Medical Devices